A quartet of ETF experts on the funds, topics and panels that will warrant the most attention this year at the Inside ETFs conference, beginning Jan. 26 in Hollywood, Florida.
Biotechnology and health care–focused funds dominated the list of those with the highest returns over the past three months.
Interest rates likely headed higher, too.
Investment costs might not seem like a big deal, but they add up and compound over time along with investment returns.
Portfolio managers have proven they cannot predictably pick winning companies consistently. They may have a better shot at weeding out the losers.
Palladium’s outdone gold and silver, big time.
Strategies focused on corporate or government debt took in more than $150 billion in the U.S. last year, the most on record
The biggest funds were among those that saw the most trading activity over the past month.
The brokerage eliminated commissions on most ETFs long before competitors did; now it's doing the same for stocks and options.